Einstein/Montefiore Department of Medicine

Department Faculty

Joel Zonszein, M.D.

Dr. Joel Zonszein

Professor of Clinical Medicine, Department of Medicine (Endocrinology)

 

Professional Interests

Joel Zonszein, M.D., C.D.E., F.A.C.E., F.A.C.P.

Dr. Joel Zonszein is the Director of the Clinical Diabetes Center at the University Hospital of the Albert Einstein College of Medicine, a Division of Montefiore Medical Center. He is Professor of Clinical Medicine at the Albert Einstein College of Medicine. Dr. Zonszein was born in México City and graduated from the "Universidad Nacional Autónoma de México" (U.N.A.M.). He trained in internal medicine at Maimonides Medical Center in Brooklyn, NY and Jacobi - Bronx Municipal Hospital Center in the Bronx, NY. His fellowship in Endocrinology and Metabolism was at Northwestern University, Chicago, Illinois and Georgetown University, Washington D.C.  Dr. Zonszein is certified by the American Boards of “Internal Medicine", "Endocrinology and Metabolism", and "Nuclear Medicine".  He has been a faculty member at Einstein since returning to New York in 1980. He headed the Division of Endocrinology and Metabolism at the Bronx Lebanon Hospital Center, Bronx, NY, and in 1993 moved full time to Einstein to develop the Clinical Diabetes Center at Montefiore Medical Center. He is a co-investigator in the Albert Einstein College of Medicine Diabetes Research Center and collaborated in landmark NIH clinically trials such as the Diabetes Control and Complication Trial (DCCT), and the Diabetes Prevention Program (DPP).  He is the principal investigator of the "Bypass Angioplasty Revascularization Investigation 2 Diabetes" (BARI2D) an ongoing NIH sponsored study to elucidate the best management of ischemic coronary heart disease in patients with type 2 diabetes. He has ample clinical experience particularly in the area of diabetes with a special interest in understanding cardiovascular disease in individuals with diabetes and or the metabolic syndrome. He developed several programs for diabetes care delivery systems with focus on the underserved minority populations. He participates as a faculty member in the Albert Einstein College of Medicine Hispanic Center of Excellence (HCOE) and a co-investigator and Scientific Director of the Bronx Center to Reduce and Eliminate Ethnic and Racial Health Disparities (BxCREED), supported by the NIH. In 2006 Dr. Zonszein procured the New York State Department of Health award as Montefiore Diabetes Center of Excellence in order to promote best practices for women with Gestational Diabetes and identify family members for diagnosis and treatment of cardiovascular risk factors such as diabetes, hypertension and dyslipidemia.

 

Selected Publications

1.   Ragucci E, Zonszein J, Frishman WH: Pharmacotherapy of diabetes mellitus: Implications for the prevention and treatment of cardiovascular disease. Heart Disease 2003; 5:1-33.

2.   Pantaleo A, Zonszein J: Using insulin as a drug rather than replacement therapy during acute illness. Heart Disease 2003;5:323-33.

3.  Caban A, Walker EA, Zonszein J: Management of Type 2 Diabetes in the Hispanic Community: Overcoming Barriers. in �Caring for Hispanic Patients� American Family Physician, July 2004.  �Caring for Hispanic Patients,� published by the AmericanAcademy of Family Physicians and the National Hispanic Medical Association

4.   Steiner G; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol. 2006 Jun 19;97(12A):9G-19G

5.  Brooks MM, Frye RL, Genuth S, Detre KM, Nesto R, Sobel BE, Kelsey SF, Orchard TJ; for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators. Hypotheses, Design, and Methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol.2006;19;97(12A):9G-19G.

6.   Magee MF, Isley WL; BARI 2D Trial Investigators. Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol. 2006 Jun 19;97(12A):20G-30G.

7.   Barsness GW, Gersh BJ, Brooks MM, Frye RL; BARI 2D Trial Investigators. Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol. 2006 Jun 19;97(12A):31G-40G

8.   Albu J, Gottlieb SH, August P, Nesto RW, Orchard TJ; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators. Modifications of coronary risk factors.
Am J Cardiol. 2006 Jun 19;97(12A):41G-52G.

9.   Sobel BE; BARI 2D Trial Investigators. Ancillary studies in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial: Synergies and opportunities. Am J Cardiol. 2006 Jun 19;97(12A):53G-58G.

10.  Hlatky MA, Melsop KA, Boothroyd DB; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators. Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease. Am J Cardiol.2006;19;97(12A):59G-65G.

11.  Boucai L, Zonszein J. Effects of Quality Improvement Strategies for Type 2 Diabetes in Bronx, N.Y. Clinical Diabetes 25: 155-159, 2007.

Selected recent textbooks, and invited reviews

12.  Frishman WH, Cavusoglu E, Zonszein J:  Magnesium, potassium, and calcium as potential cardiovascular disease therapies. In Frishman WH, Sonnenblick EH (eds): Cardiovascular Pharmacotherapeutics, Companion Handbook. New York, McGraw-Hill, 1998:175-82.

13.  Zonszein J, Sonnenblick EH: The Heart and Endocrine Diseases (Ch 25). In: Alexander RW, Schlant RC, Fuster V, O=Rourke RA, Roberts R, Sonneblick EH (eds): Hurst=s The Heart Companion Handbook.  New York, McGraw-Hill, 1999:419-32.

14.  Zonszein J. Guest Editor (Spanish). Update in Diabetes. ADiabetes: La Epidemia en la Poblacion Latina. Introduction: The Diabetes Epidemic in the Latino Population. Medico Interamericano 2000;19:405

15.  Zonszein J: Treatment of Diabetes in the Elderly (Ch IV.17). In: Lunenfeld B, Gooren L, (eds): Textbook of Men�s Health. New York, the Parthenon Publishing Group, 2002:207-24

16.  Mayers J. Zonszein J: Diagnostic Criteria and Classification of Diabetes (Ch III.1). In: Poretsky L (eds):  Principles of Diabetes Mellitus. Kluwer Academic Publishers, 2002:95-106.

17.  Leu J. Zonszein J: Diagnostic Criteria and Classification of Diabetes (Ch III.1). In: Poretsky L (eds):  Principles of Diabetes Mellitus. Kluwer Academic Publishers, in press

 

More Information About Dr. Joel Zonszein

Diabetes Research Center

Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.

Contact

Jack D. Weiler Hospital
1825 Eastchester Road
Bronx, NY 10461

Tel: 718.904.2883
Fax: 718.904.2114
joel.zonszein@einstein.yu.edu

 
Pubmed Search
Collexis Research Profiles
Einstein Research Profiles (ERP) is one of the innovative technologies to create collaborative bridges within and across the entire bench-to-bedside-to-population spectrum of research. The ERP website has been developed in partnership with Collexis to give investigators easy access to PubMed publications, coauthor networks, information about NIH grants, and research networks.

Media Coverage

CBSNews.com interviews Dr. Joel Zonszein about a new report that found diabetes-related health complications have declined, including stroke.

Contrary to expectations, fish oil doesn’t help diabetics' hearts, reports U.S. News & World Report in an article quoting Dr. Joel Zonszein. 

More media coverage